Terry A. Beerman - Publications

State University of New York, Buffalo, Buffalo, NY, United States 
Molecular Biology, Pharmaceutical Chemistry

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Beerman TA, Gawron LS, Shen B, Kennedy DR. The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance. Dna Repair. 21: 165-70. PMID 24986640 DOI: 10.1016/j.dnarep.2014.06.001  0.48
2012 San Pedro JM, Beerman TA, Greenberg MM. DNA damage by C1027 involves hydrogen atom abstraction and addition to nucleobases. Bioorganic & Medicinal Chemistry. 20: 4744-50. PMID 22748380 DOI: 10.1016/j.bmc.2012.06.004  0.48
2009 Beerman TA, Gawron LS, Shin S, Shen B, McHugh MM. C-1027, a radiomimetic enediyne anticancer drug, preferentially targets hypoxic cells. Cancer Research. 69: 593-8. PMID 19147573 DOI: 10.1158/0008-5472.CAN-08-2753  0.36
2007 Kennedy DR, Gawron LS, Ju J, Liu W, Shen B, Beerman TA. Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks. Cancer Research. 67: 773-81. PMID 17234789 DOI: 10.1158/0008-5472.CAN-06-2893  0.36
2006 Dziegielewska B, Beerman TA, Bianco PR. Inhibition of RecBCD enzyme by antineoplastic DNA alkylating agents. Journal of Molecular Biology. 361: 898-919. PMID 16887143 DOI: 10.1016/j.jmb.2006.06.068  0.6
2005 McHugh MM, Gawron LS, Matsui S, Beerman TA. The antitumor enediyne C-1027 alters cell cycle progression and induces chromosomal aberrations and telomere dysfunction. Cancer Research. 65: 5344-51. PMID 15958582 DOI: 10.1158/0008-5472.CAN-05-0015  0.36
2005 Philips BJ, Chang AY, Dervan PB, Beerman TA. DNA damage effects of a polyamide-CBI conjugate in SV40 virions. Molecular Pharmacology. 67: 877-82. PMID 15576630 DOI: 10.1124/mol.104.006254  0.48
2004 Dziegielewska B, Kowalski D, Beerman TA. SV40 DNA replication inhibition by the monofunctional DNA alkylator Et743. Biochemistry. 43: 14228-37. PMID 15518573 DOI: 10.1021/bi049407x  0.6
2003 Wang YD, Dziegielewski J, Wurtz NR, Dziegielewska B, Dervan PB, Beerman TA. DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate. Nucleic Acids Research. 31: 1208-15. PMID 12582240 DOI: 10.1093/nar/gkg215  0.48
2003 Liu JS, Kuo SR, Beerman TA, Melendy T. Induction of DNA damage responses by adozelesin is S phase-specific and dependent on active replication forks Molecular Cancer Therapeutics. 2: 41-47. PMID 12533671  0.48
2002 Wang YD, Dziegielewski J, Chang AY, Dervan PB, Beerman TA. Cell-free and cellular activities of a DNA sequence selective hairpin polyamide-CBI conjugate. The Journal of Biological Chemistry. 277: 42431-7. PMID 12196541 DOI: 10.1074/jbc.M207179200  0.48
2002 Belitsky JM, Leslie SJ, Arora PS, Beerman TA, Dervan PB. Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorganic & Medicinal Chemistry. 10: 3313-8. PMID 12150878 DOI: 10.1016/S0968-0896(02)00204-3  0.48
2002 White CM, Satz AL, Gawron LS, Bruice TC, Beerman TA. Inhibiting transcription factor/DNA complexes using fluorescent microgonotropens (FMGTs). Biochimica Et Biophysica Acta. 1574: 100-8. PMID 11955618 DOI: 10.1016/S0167-4781(01)00351-7  0.48
2001 White CM, Satz AL, Bruice TC, Beerman TA. Inhibition of transcription factor-DNA complexes and gene expression by a microgonotropen. Proceedings of the National Academy of Sciences of the United States of America. 98: 10590-5. PMID 11535831 DOI: 10.1073/pnas.191374698  0.48
2001 Satz AL, White CM, Beerman TA, Bruice TC. Double-stranded DNA binding characteristics and subcellular distribution of a minor groove binding diphenyl ether bisbenzimidazole. Biochemistry. 40: 6465-74. PMID 11371210 DOI: 10.1021/bi0103415  0.48
2000 White CM, Heidenreich O, Nordheim A, Beerman TA. Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target. Biochemistry. 39: 12262-73. PMID 11015205 DOI: 10.1021/bi001427l  0.48
Show low-probability matches.